Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nevro Corp (NVRO)

Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nevro Corp 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065 USA

www.nevro.com P: 650-251-0005

Description:

Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.

Key Statistics

Overview:

Market Capitalization, $K 414,128
Enterprise Value, $K 521,378
Shares Outstanding, K 36,681
Annual Sales, $ 425,170 K
Annual Net Income, $ -92,210 K
Last Quarter Sales, $ 116,180 K
Last Quarter Net Income, $ -8,980 K
EBIT, $ -99,060 K
EBITDA, $ -90,250 K
60-Month Beta 0.96
% of Insider Shareholders 3.20%
% of Institutional Shareholders 95.52%
Float, K 35,507
% Float 96.80%
Short Volume Ratio 0.44

Growth:

1-Year Return -59.06%
3-Year Return -92.77%
5-Year Return -81.25%
5-Year Revenue Growth 9.78%
5-Year Earnings Growth -50.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 02/21/24
Latest Earnings Date 05/07/24 [AMC]
Earnings Per Share ttm -2.47
EPS Growth vs. Prev Qtr 76.92%
EPS Growth vs. Prev Year 72.22%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NVRO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -30.22%
Return-on-Assets % -15.17%
Profit Margin % -21.69%
Debt/Equity 0.72
Price/Sales 0.96
Price/Cash Flow N/A
Price/Book 1.29
Book Value/Share 8.10
Interest Coverage -11.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar